marijuana stocks

The Rosen Law Firm Announces Investigation of Securities Claims Against Medbox, Inc. – MDBX


The Rosen Law Firm announces that it is investigating potential securities fraud claims against Medbox, Inc. (“MDBX”) resulting from evidence that the Company may have issued materially misleading financial information to the investing public.

On December 30, 2014, Medbox announced that its financial statements for: (i) the year ended December 31, 2013, (ii) the third and fourth quarters of 2013, and (iii) the first and second quarters of 2014 can no longer be relied upon, as they are materially inaccurate. Specifically, Medbox admitted that an internal investigation by its Audit Committee revealed that Medbox improperly recognized revenue, in violation of Generally Accepted Auditing Principles (“GAAP”). As a result of this adverse news, the value of Medbox stock fell from $5.98 to $5.11, or 14.5%, when the market opened on December 30, 2014.

The Rosen Law Firm is preparing a securities class action lawsuit on behalf of Medbox investors. If you purchased Medbox stock between November 20, 2013 and December 29, 2014, please visit the website at to join the class action or for more information. You may also contact Phillip Kim, Esq. or Laurence Rosen, Esq. of The Rosen Law Firm toll free at 866-767-3653 or via e-mail at or

The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.

Attorney Advertising. Prior results do not guarantee a similar outcome.

The Rosen Law Firm P.A.
Laurence Rosen, Esq.
Phillip Kim, Esq.
Kevin Chan, Esq.
275 Madison Avenue 34 th Floor
New York, New York 10016
Tel: (212) 686-1060
Toll Free: 1-866-767-3653
Fax: (212) 202-3827

MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 |
Leave a Reply

Your email address will not be published.

You May Also Like

$ERBB Board of Directors Selects Miller as CEO

American Green Board of Directors Selects Miller as CEO American Green, Inc.…

 AbbVie (ABBV) Receives European Commission Approval of VENCLYXTO®

AbbVie Receives European Commission Approval of VENCLYXTO® (venetoclax) in Combination with a…

Tauriga Sciences, Inc. (TAUG ) Fully Retires $104,000 7.00% USD Convertible Debenture Issued to Union Capital LLC

Tauriga Sciences, Inc. ( OTC PINK :TAUG ) (“Tauriga” or the “Company”), a company engaged…